Showing results (261-270 of 1,008) with videos related to
Sort By:
Pageof 101
Nutrients|December 6, 2016
Do Health Claims and Front-of-Pack Labels Lead to a Positivity Bias in Unhealthy Foods?Zenobia Talati, Simone Pettigrew, Helen Dixon, et al.Current Developments in Nutrition|November 11, 2024
Health Claims, Product Features and Instructions for Use on the Labels of Potassium-enriched Salt Products: A Content AnalysisJames Bullen, Xuejun Yin, Katrina Kissock, et al.Expert Review of Endocrinology & Metabolism|February 21, 2019
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trialRohina Joshi, Be de Galan, John Chalmers, et al.BMJ Open|September 1, 2016
Is poor oral health a risk marker for incident cardiovascular disease hospitalisation and all-cause mortality? Findings from 172 630 participants from the prospective 45 and Up StudyGrace Joshy, Manish Arora, Rosemary J Korda, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 6, 2007
New insights from ADVANCEJohn Chalmers, Andre-Pascal Kengne, Rohina Joshi, et al.Health Policy (Amsterdam, Netherlands)|February 27, 2017
Using administrative data to look at changes in the level and distribution of out-of-pocket medical expenditure: An example using Medicare data from AustraliaXinyang Hua, Guido Erreygers, John Chalmers, et al.International Journal of Epidemiology|May 5, 2016
Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adultsConnor A Emdin, Simon G Anderson, Gholamreza Salimi-Khorshidi, et al.Lancet (London, England)|February 1, 2005
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular riskRod Jackson, Carlene M M Lawes, Derrick A Bennett, et al.Eclinicalmedicine|August 18, 2023
Ketamine for the treatment of major depression: a systematic review and meta-analysisStevan Nikolin, Anthony Rodgers, Andreas Schwaab, et al.Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.Pageof 101